Could a cell infusion free liver transplant patients from lifelong drugs?
NCT ID NCT03164265
First seen Oct 01, 2025 · Last updated May 22, 2026 · Updated 32 times
Summary
This study tested whether a single infusion of specially prepared donor immune cells (called regulatory dendritic cells) given before a liver transplant could help recipients safely stop taking anti-rejection medications. Sixteen low-risk living donor liver transplant patients received the cell infusion and were followed for several years. The goal was to see if patients could achieve 'operational tolerance'—meaning their body accepts the new liver without needing lifelong drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVING DONOR LIVER TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UPMC
Pittsburgh, Pennsylvania, 15261, United States
Conditions
Explore the condition pages connected to this study.